Restless Legs Syndrome and Paroxetine

Overview

Journal Acta Psychiatr Scand

Specialty Psychiatry

Date 1996 Dec 1

PMID 9021005

Citations 10

Authors

A Huidobro

Affiliations

Soon will be listed here.

Abstract

Restless legs syndrome is a frequent dyssomnia with well-known clinical features but uncertain origin and treatment. This paper describes a case of restless legs syndrome worsened by paroxetine. A possible pathogenic hypothesis related to the attributed neurochemical properties of the drug is proposed.

Citing Articles

Restless legs syndrome following the use of ziprasidone: a case report.

Zhu C, Bi R, Hu Y, Zhou H, Zhu D, Isaacson B Gen Psychiatr. 2020; 33(2):e100112.

PMID: 32215360 PMC: 7066599. DOI: 10.1136/gpsych-2019-100112.

Medications associated with restless legs syndrome: a case-control study in the US Renal Data System (USRDS).

Bliwise D, Zhang R, Kutner N Sleep Med. 2014; 15(10):1241-5.

PMID: 25156752 PMC: 4172448. DOI: 10.1016/j.sleep.2014.05.011.

Strategies for the treatment of restless legs syndrome.

Buchfuhrer M Neurotherapeutics. 2012; 9(4):776-90.

PMID: 22923001 PMC: 3480566. DOI: 10.1007/s13311-012-0139-4.

Pharmacologically induced/exacerbated restless legs syndrome, periodic limb movements of sleep, and REM behavior disorder/REM sleep without atonia: literature review, qualitative scoring, and comparative analysis.

Hoque R, Chesson Jr A J Clin Sleep Med. 2010; 6(1):79-83.

PMID: 20191944 PMC: 2823282.

Depressive disorders in restless legs syndrome: epidemiology, pathophysiology and management.

Hornyak M CNS Drugs. 2010; 24(2):89-98.

PMID: 20088617 DOI: 10.2165/11317500-000000000-00000.